The European Union’s drug regulator says it has found a “possible link” between the AstraZeneca coronavirus vaccine and a rare clotting disorder but says the benefits of the shot still outweigh risks.
In a statement released Wednesday, the European Medicines Agency placed no new restrictions on using the vaccine in people 18 and over.
The EMA says most of the cases reported have occurred in women under 60 within two weeks of vaccination. The agency says based on the currently available evidence, it was not able to identify specific risk factors.
Experts reviewed several dozen cases that came mainly from Europe and the United Kingdom, where around 25 million people have received the AstraZeneca vaccine.
The EMA, the World Health Organization and numerous other health authorities have repeatedly stated the AstraZeneca vaccine is safe and effective and the protection it offers against COVID-19 outweighs the small risks of rare blood clots.
READ ALSO:
